Cancer Gene Therapy Market By Therapy (Gene Induced Immunotherapy (Delivery of Cytokines Gene, Delivery of Tumor Antigen Gene), Oncolytic Virotherapy (Adenovirus, Lentivirus, Retro Virus, Adeno Associated Virus, Herpes Simplex Virus, Alpha Virus, Vaccinia Virus, Simian Virus, Others), Gene Transfer (Naked/Plasmid Vectors (Electroporation, Sonoportion, Magnetofection, Gene Gun)), Industry Trends, Estimation & Forecast, 2017 - 2025
Cancer Gene Therapy Market is expected to grow with a CAGR of x.x% during the forecast period of 2018 to 2025.
Cancer takes place as a result of the production of multiple mutations in a single cell that causes it to proliferate out of control. Cancer cells can be differentiated from their usual neighbors on the basis of specific phenotypic changes, such as rapid division rate, attack of new cellular areas, high metabolic rate, and altered shape. The cancer patients who are not cured by surgeries, radiations, and chemotherapies, are treated by gene therapy. Gene therapy is the insertion of a functional gene into the cells of a patient to correct an inborn error of metabolism, in order to alter or repair an acquired genetic abnormality, and to provide a new function to a cell. Owing to high success rate throughout the preclinical and clinical trials, cancer gene therapy is gaining popularity.
Cancer Gene Therapy Market Determinants
Improvised technological advancements, increased adoption of developing genomic technologies such as next generation sequencing (NGS) and high density micro array are some of the major factors that will drive the global cancer gene therapy market in next upcoming years. Additionally, increasing number of cancer cases will increase the demand for gene therapy as an effective personalized treatment choice. However, high cost of gene therapy treatment and unwanted immune responses are the major factors restraining the growth of cancer gene therapy. On the other hand, ethical acceptance of gene therapy for cancers, untapped markets in developing economies and the technological progressions principal to higher adoption rate are expected to provide new paths for the growing of cancer gene therapy market in the future.
Cancer Gene Therapy Market Key Segments:
• By Therapy
o Gene Induced Immunotherapy
Delivery of Cytokines Gene
Delivery of Tumor Antigen Gene
o Oncolytic Virotherapy
Adeno Associated Virus
Herpes Simplex Virus
o Gene Transfer
• By End User
• By Geography
o North America
Rest of Europe
Rest of Asia-Pacific
o Rest of World
Rest of World
Table of Content
o OncoGenex Pharmaceuticals
o SynerGene Therapeutics
o Shenzhen SiBiono GeneTech
o Shanghai Sunway Biotech
o Bluebird bio, Inc.
What Information does this report contain?
What was the market size of the Cancer Gene Therapy Market in 2017 and the expected market size by 2025, along with the growth rate?
An in-depth analysis of the current impacting factors, opportunities and challenges/restraints in the market
Which are the largest revenue generating products, services or regions and their comparative growth rate?
Which technology is in trend and how would it evolve during the forecast period (2017 – 2025)?
Which are the leading companies in the Cancer Gene Therapy Market and their competitive positioning basis their market share, product portfolio, strategic attempts and business focus?